Measure | PGI-S-AD category | POEM category | ||||
---|---|---|---|---|---|---|
≤ 3 (no to mild symptoms) | > 3 (moderate to severe symptoms) | 0–7 (clear to mild) | 8–16 (moderate to severe) | 17–28 (severe to very severe) | ||
Itch NRS | BREEZE-AD1 | |||||
Sample size | 118 | 497 | 13 | 125 | 470 | |
LSM (SE) at baseline | 4.22 (0.296) | 7.43 (0.254) | N/Ab | 5.35 (0.322) | 7.46 (0.283) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | < 0.0001 | |
BREEZE-AD2 | ||||||
Sample size | 110 | 490 | 26 | 126 | 445 | |
LSM (SE) at baseline | 3.58 (0.502) | 6.79 (0.471) | 3.05 (0.628) | 5.09 (0.537) | 6.89 (0.510) | |
Between-group comparisonsa | – | < 0.0001 | – | < 0.0001 | < 0.0001 | |
BREEZE-AD5 | ||||||
Sample size | 61 | 364 | 9 | 72 | 342 | |
LSM (SE) at baseline | 3.95 (0.328) | 7.59 (0.260) | N/Ab | 4.89 (0.362) | 7.29 (0.286) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | < 0.0001 | |
Skin pain NRS | BREEZE-AD1 | |||||
Sample Size | 118 | 497 | 13 | 125 | 470 | |
LSM (SE) at baseline | 3.36 (0.372) | 6.73 (0.319) | N/Ab | 4.58 (0.394) | 6.75 (0.346) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | < 0.0001 | |
BREEZE-AD2 | ||||||
Sample size | 110 | 490 | 26 | 126 | 445 | |
LSM (SE) at baseline | 2.94 (0.617) | 6.29 (0.580) | 1.96 (0.723) | 4.09 (0.619) | 6.47 (0.587) | |
Between-group comparisonsa | – | < 0.0001 | – | < 0.0001 | < 0.0001 | |
BREEZE-AD5 | ||||||
Sample size | 61 | 364 | 9 | 72 | 342 | |
LSM (SE) at baseline | 3.55 (0.436) | 7.07 (0.345) | N/Ab | 4.05 (0.446) | 6.83 (0.353) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | < 0.0001 | |
ADSS item 1 | BREEZE-AD1 | |||||
Sample size | 118 | 497 | 13 | 125 | 470 | |
LSM (SE) at baseline | 1.04 (0.167) | 2.36 (0.143) | N/Ab | 1.45 (0.174) | 2.38 (0.152) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | < 0.0001 | |
BREEZE-AD2 | ||||||
Sample size | 110 | 490 | 26 | 126 | 445 | |
LSM (SE) at baseline | 1.06 (0.286) | 2.29 (0.269) | 0.94 (0.341) | 1.53 (0.292) | 2.34 (0.277) | |
Between-group comparisonsa | – | < 0.0001 | – | 0.0089 | < 0.0001 | |
BREEZE-AD5 | ||||||
Sample size | 61 | 364 | 9 | 72 | 342 | |
LSM (SE) at baseline | 1.04 (0.201) | 2.54 (0.159) | N/Ab | 1.38 (0.209) | 2.43 (0.165) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | < 0.0001 | |
ADSS item 2 | BREEZE-AD1 | |||||
Sample size | 118 | 497 | 13 | 125 | 470 | |
LSM (SE) at baseline | 1.18 (0.809) | 3.22 (0.694) | N/A^b | 1.36 (0.805) | 3.35 (0.706) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | 0.0001 | |
BREEZE-AD2 | ||||||
Sample size | 110 | 490 | 26 | 126 | 445 | |
LSM (SE) at baseline | 1.00 (0.622) | 2.11 (0.585) | 0.91 (0.727) | 1.46 (0.622) | 2.15 (0.590) | |
Between-group comparisonsa | – | < 0.0001 | – | 0.2514 | 0.0024 | |
BREEZE-AD5 | ||||||
Sample Size | 61 | 364 | 9 | 72 | 342 | |
LSM (SE) at baseline | 1.12 (0.525) | 2.87 (0.416) | N/Ab | 1.32 (0.529) | 2.79 (0.418) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | 0.0001 | |
ADSS item 3 | BREEZE-AD1 | |||||
Sample Size | 63 | 442 | 10 | 74 | 415 | |
LSM (SE) at baseline | 1.42 (0.175) | 2.46 (0.136) | N/Ab | 1.74 (0.172) | 2.50 (0.139 | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | < 0.0001 | |
BREEZE-AD2 | ||||||
Sample size | 60 | 423 | 11 | 84 | 385 | |
LSM (SE) at baseline | 1.30 (0.267) | 2.35 (0.240) | N/Ab | 1.63 (0.266) | 2.38 (0.247) | |
Between-group comparisonsa | – | < 0.0001 | – | N/Ab | < 0.0001 | |
BREEZE-AD5 | ||||||
Sample size | 38 | 324 | 4 | 48 | 309 | |
LSM (SE) at baseline | 1.53 (0.190) | 2.82 (0.137) | N/Ab | 2.02 (0.195) | 2.72 (0.143) | |
Between-group comparisonsa | – | < 0.0001 | - | N/Ab | < 0.0001 |